Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
AIM2-driven inflammasome activation in heart failure
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.